Does p53 status influence tumor response to anticancer therapies?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Does p53 status influence tumor response to anticancer therapies?

Published:2000-07 Issue:6 Volume:11 Page:419-432
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:Anti-Cancer Drugs

Author:

Pirollo Kathleen F,Bouker Kerrie B,Chang Esther H

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference119 articles.

1. p53-Oriented cancer therapies: Current progress

2. Regulators and mediators of the p53 tumor suppressor

3. The p53 pathway

4. Mechanisms of p53-mediated apoptosis

5. p53 Mutations in Human Cancers

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oleuropein and its hydrolysate from extra virgin olive oil inhibit breast cancer cells proliferation interfering with the PI3K-AKT signal pathway;Journal of Functional Foods;2023-11

2. CSE1L is a negative regulator of the RB-DREAM pathway in p53 wild-type NSCLC and can be targeted using an HDAC1/2 inhibitor;Scientific Reports;2023-09-27

3. CSE1L is a negative regulator of the RB-DREAM pathway in p53 wild-type NSCLC and can be targeted using an HDAC1/2 inhibitor;2023-06-09

4. RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC;Scientific Reports;2022-01-20

5. TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation;International Journal of Molecular Sciences;2021-10-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3